BOSC.NASDAQBos Better Online Solutions LTD

20-F: BOS Reports Strong 2025 Growth Driven by Defense Sector

Sentiment:

Annual Report 31 March 2026 3:20 PM

📋All filings for Bos Better Online Solutions LTD

B.O.S. Better Online Solutions Ltd. announced a significant increase in revenues and net income for fiscal year 2025, primarily fueled by heightened demand in the defense sector.

Capital raiseIn September 2025, the company entered into a sales agreement with A.G.P./Alliance Global Partners for the sale of up to $4 million of Ordinary Shares in an at-the-market offering.The company may need to significantly increase its debt and raise additional equity financing to fund future acquisitions for business growth.

Better than expectedRevenues increased by 26.5% to $50.5 million, significantly higher than the previous year.Net income grew by 56.5% to $3.6 million, demonstrating strong profitability improvement.Operating cash flow increased substantially to $5 million, indicating robust cash generation.Working capital improved to $22.4 million, enhancing the company's liquidity position.

Summary

Revenues for 2025 increased by 26.5% to $50.5 million, up from $40 million in 2024.
Net income for 2025 was $3.6 million, a 56.5% increase from $2.3 million in 2024.
Gross profit reached $12.1 million in 2025, with a gross profit margin of 23.9%, compared to $9.3 million and 23.5% in 2024.
Operating cash flow significantly improved to $5 million in 2025 from $1.3 million in 2024.
Working capital increased to $22.4 million as of December 31, 2025, from $13.7 million in 2024.
The Supply Chain Solutions division saw revenues jump by 37.6% to $35.5 million, driven by geopolitical tensions in Israel and Europe.
The RFID division's revenues increased by 5.5% to $13.6 million, but its gross profit margin decreased due to operational inefficiencies and an unfavorable product mix.
The Intelligent Robotics division's revenues grew by 3.1% to $1.85 million, with over 90% of its backlog now attributed to the Israeli defense sector.
The company recorded goodwill impairment charges of $1.2 million in 2025, following a $0.7 million impairment in 2024, primarily due to the negative impact of political tensions on the Israeli commercial market affecting the RFID division.
Financial income improved to $590,000 in 2025 from a $139,000 expense in 2024, largely due to foreign exchange gains from the NIS appreciating against the U.S. dollar.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance, with significant revenue and net income growth driven by strategic alignment with the defense sector, despite some operational challenges and geopolitical risks.

Positives

Total revenues increased by 26.5% to $50.5 million in 2025, demonstrating strong top-line growth.
Net income grew by 56.5% to $3.6 million in 2025, indicating improved profitability.
Operating cash flow saw a substantial increase to $5 million in 2025, reflecting healthy cash generation from core operations.
Working capital improved significantly to $22.4 million, enhancing liquidity and financial flexibility.
The Supply Chain Solutions division experienced robust revenue growth of 37.6%, benefiting from increased demand in the defense sector.
The Intelligent Robotics division successfully transitioned its focus to the Israeli defense sector, with 90% of its backlog now serving this rapidly growing market.
The company reported positive net income for the third consecutive fiscal year, reversing a history of losses prior to 2022.
All outstanding warrants from 2019 and 2021 offerings were exercised in 2025, generating $2.97 million in cash proceeds.

Negatives

The RFID division's gross profit margin decreased from 27.4% in 2024 to 21.3% in 2025, attributed to operational inefficiencies and an unfavorable product mix.
Ongoing political tensions in Israel negatively impacted the Israeli commercial market, which is the primary revenue base for the RFID division, leading to a cumulative revenue decline of 12% between 2022 and 2025 for this segment.
Goodwill impairment charges totaled $1.2 million in 2025, following $0.7 million in 2024, primarily due to the underperformance and negative outlook for the RFID division in the Israeli commercial market.
The company has an accumulated deficit of $61 million as of December 31, 2025, despite recent profitable years.

Risks

Unpredictable future sales and ability to achieve sustained profitability.
Inability to maintain current gross profit margins due to product mix, supplier prices, or competition.
Dependence on two primary banks (First International Bank of Israel and Bank Leumi) for credit facilities, with assets subject to security interests.
Debt obligations may hinder growth, limit business opportunities, and make the company vulnerable to economic downturns.
Loan agreements contain conditions and limitations on operations, including raising debt, selling/acquiring assets, and paying dividends, and require maintaining certain financial ratios.
Reliance on certain key suppliers, with 52% of Supply Chain Solutions division purchases from five key suppliers in 2025, and 22% from Positronics Manufacturing Company.
Dependence on key personnel, including CEO Eyal Cohen and President Avidan Zelicovsky, and competition for skilled employees.
Inability to effectively manage growth and expansion, including retaining personnel, assimilating cultures, preserving business relationships, and maintaining uniform standards.
Lack of collateral or credit insurance for all customer debt, potentially leading to increased allowances for credit losses.
Risk of customer cancellations of purchase orders in the Supply Chain Solutions division, potentially resulting in excess and obsolete inventory.
Products needing to meet industry standards (e.g., Aviation Standard 9120) and the need to be authorized distributors for certain manufacturers.
Potential for product defects, which could be costly to correct, delay market acceptance, harm reputation, and lead to litigation.
Risk of infringing on the intellectual property rights of others, leading to costly litigation or licensing agreements.
Non-compliance with U.S. Government procurement laws and regulations, including import-export control and the FCPA, could result in civil or criminal fines.
Future changes in industry standards may render inventory obsolete and unmarketable.
Existing and proposed Israeli legal requirements for minimum wage and work hours may increase labor-related expenses.
Revenue levels falling significantly below expectations in any quarter could adversely affect operating results.
Inflation in Israel exceeding the rate of NIS devaluation against the U.S. dollar could negatively impact costs.
Inability to successfully introduce new products could hinder business expansion.
Disruptions to IT systems due to system failures or cybersecurity attacks, potentially compromising sensitive information and exposing the company to liability.
Risks inherent in international transactions, including collecting receivables, governmental controls, political/economic instability, foreign currency exchange rate risk, and trade restrictions.
Unfavorable global economic conditions, including the potential return of the COVID-19 pandemic.
Environmental, social, and governance (ESG) matters may impact business and reputation.
Obligation to indemnify directors and officers, potentially affecting financial condition.
Risk of being classified as a Passive Foreign Investment Company (PFIC) for U.S. federal income tax purposes, with adverse tax consequences for U.S. shareholders.
A decline in market capitalization or other factors could require a write-down of goodwill, materially affecting results of operations.
Actions by activist shareholders could be costly, time-consuming, and divert management attention.
Failure to maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act.
Employee fraud or misconduct, including noncompliance with regulatory standards or insider trading, could negatively impact reputation and share price.
Share price volatility, which could result in substantial losses for shareholders.
Future sales of Ordinary Shares by the company or existing shareholders could cause the stock price to decline.
Potential delisting from the Nasdaq Stock Market due to failure to meet continued listing requirements.
Political, economic, and security conditions in Israel, including ongoing conflicts, military reserve duty for key personnel, and credit rating downgrades, could adversely affect operations and ability to raise capital.
Commercial insurance does not cover losses from security situations in the Middle East.
Restrictive laws or policies directed towards Israel or Israeli businesses could impact operations.
Anti-takeover effects of Israeli laws may delay or deter a change of control.
Uncertain enforceability of civil liabilities against non-U.S. resident directors and officers.
Shareholder rights and responsibilities governed by Israeli law, which differ from U.S. corporations.
Reliance on the foreign private issuer exemption for certain Nasdaq corporate governance requirements, potentially affording less protection to shareholders.
Loss of foreign private issuer status would incur additional compliance expenses.
Significant accounting, legal, and other expenses as a U.S. public company, with potential for increased costs from new compliance initiatives.

Future Outlook

The company aims to become a leading integrator of comprehensive technological solutions for inventory control and productivity in production and logistics. A significant factor driving future growth is the substantial portion of revenues derived from the expanding defense sector. The company plans to invest throughout 2026 in expanding its RFID division into more stable regulated sectors, including medical and defense, with revenue contributions expected to begin in 2027, subject to successful execution.

Management Comments

Management believes current working capital is sufficient for ongoing operations.
Management is actively addressing operational inefficiencies identified in the RFID division during 2025 through operational improvement measures.
Management regularly monitors developments in regional conflicts and acts in accordance with authorities' guidelines, believing there is no significant impact on activities as of the financial statements' approval date.

Industry Context

StockSavvy.ai notes that BOS's strong performance in 2025, particularly its Supply Chain Solutions division, is directly linked to heightened geopolitical tensions in Israel and Europe, driving increased demand in the defense sector. This aligns with a broader global trend of rising defense spending. The strategic shift of the Intelligent Robotics division to the Israeli defense sector and plans to expand the RFID division into medical and defense markets demonstrate a proactive approach to capitalize on resilient and growing sectors, mitigating exposure to the volatile Israeli commercial market. Competitors like Arrow Electronics International Inc. and Avnet Electronics Marketing in the supply chain space, and eWave mobile Ltd. in RFID, operate in dynamic markets, making BOS's focused strategy on defense and specialized solutions a key differentiator.

Comparison to Industry Standards

The 26.5% revenue growth and 56.5% net income growth in 2025 are robust, potentially outperforming many industry peers in the broader technology and supply chain sectors, especially given the challenging global economic environment.
The gross profit margin of 23.9% for 2025 is a slight improvement and indicates effective cost management or a favorable product mix, which can be competitive within the specialized electronics distribution and robotics integration markets.
The significant increase in operating cash flow to $5 million suggests strong operational efficiency and liquidity generation, which is a positive indicator compared to companies heavily reliant on external financing.
The company's focus on the defense sector, with major customers like Israel Aerospace Industries, Elbit Systems, and Rafael, positions it within a high-growth, high-barrier-to-entry market, potentially offering more stable and higher-margin contracts compared to general commercial markets.

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Chairman of the Board of Directors	NA	Ms. Osnat Gur	March 2025	Appointment to expanded role.
Director	NA	Mr. Avi Dadon	March 2025	Appointment to the Board.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Composition	The Board of Directors is comprised of 4 directors, classified into three separate classes with staggered three-year terms. Directors are elected at annual shareholders meetings.	October 31, 2019 (amended Articles of Association)	This classified board structure may increase the time required for a takeover, potentially limiting opportunities for shareholders to receive a premium.
External Directors Exemption	The company has opted out of the Israeli Companies Law requirement to appoint External Directors, following Israeli law and practice as a foreign private issuer.	October 16, 2017	Shareholders may not be afforded the same protection as provided under Nasdaq's corporate governance rules for domestic issuers.
Shareholder Approval for Private Placements	The company follows Israeli law and practice, which does not require shareholder approval for private placements in a public company whose shares are traded only outside of Israel, in lieu of Nasdaq rules.	NA	This practice differs from Nasdaq requirements and may provide less protection to investors regarding potential dilution.
Indemnification Agreements	Shareholders approved a modified form of indemnification agreement for directors and officers, providing protection to the fullest extent permitted by law, up to an aggregate of $2.5 million in excess of insurance proceeds.	October 30, 2025	Aims to attract and retain qualified directors and officers, but payments could materially adversely affect financial condition.
Clawback Policy	A clawback policy, compliant with Nasdaq listing rules, was adopted.	December 14, 2023	Enhances corporate accountability by allowing the company to recover incentive-based compensation under certain circumstances.
Director Compensation	Annual compensation for directors increased to NIS 40,000 (approx. $11,000) from 2025. Chairman's annual compensation increased to NIS 70,000 (approx. $22,563) retroactively from March 2025.	Commencing 2025	Aims to attract and retain qualified board members, reflecting the expanded role of the Chairman.
Option Grant for Directors/Officers	Shareholders approved an increase in the triennial option grant to 15,000 Ordinary Shares (from 7,500) for directors and officers.	December 2024	Intended to align the interests of directors and officers with shareholders through equity participation.

Related Party Transactions

The company charged its subsidiaries, Odem and Dimex, management fees totaling $2,775,000 in 2025 and $2,287,000 in 2024.
The company has provided indemnity undertakings to its directors and officers, approved by shareholders, for up to $2,500,000 in excess of insurance proceeds.

Stakeholder Impact

Shareholders: Benefited from increased net income and EPS, but face risks from geopolitical instability, potential share price volatility, and dilution from future capital raises.
Employees: Subject to Israeli labor laws, including minimum wage increases, and potential military reserve duty due to regional conflicts.
Customers: Defense sector customers are experiencing increased demand, leading to higher sales for the company. Other customers may face supply chain disruptions or product standard compliance issues.
Suppliers: The company's reliance on key suppliers, particularly Positronics Manufacturing Company, creates a dependency risk for its Supply Chain Solutions division.
Creditors: The company's debt obligations and covenants with banks (First International Bank of Israel and Bank Leumi) require maintaining certain financial ratios, impacting its ability to obtain additional financing.

Next Steps

Invest throughout 2026 in expanding the RFID division into more stable regulated sectors, including medical and defense.
Broaden product offerings and hire personnel with relevant domain expertise for new sector expansion.
Establish new customer relationships in medical and defense sectors for the RFID division.
Expect revenue contributions from RFID expansion initiatives to begin in 2027.

Key Dates

Date	Description
1990	Company incorporated in Israel.
April 1996	Ordinary Shares began trading on the over-the-counter market (now Nasdaq Capital Market).
April 2, 2000	Warrants expired.
September 2000	Ordinary Shares began trading on the Nasdaq Global Market.
January 2002	Shares began trading on the TASE.
May 2003	Shareholders approved the 2003 Israeli Share Option Plan.
November 2004	Acquisition of Odem, leading to Avidan Zelicovsky joining BOS.
May 12, 2009	Delisted Ordinary Shares from the TASE.
October 16, 2009	Ordinary Shares transferred to the Nasdaq Capital Market.
December 2012	Amendment 20 to the Israeli Companies Law became effective; shareholders approved a 10-year extension to the Share Option Plan.
January 2016	Completed the acquisition of assets of iDnext Ltd. and its subsidiary Next-Line Ltd.
October 2017	Replaced all Bank Leumi credit facilities with Bank Beinleumi; opted out of the requirement to appoint External Directors.
January 2018	Israeli corporate tax rate became 23%.
July 18, 2018	Shareholders approved an increase of 200,000 Ordinary Shares in the pool for the Plan (total 700,000) and an amendment allowing for the grant of Ordinary Shares.
May 16, 2019	Entered into a securities purchase agreement for the sale of 400,000 Ordinary Shares and 240,000 warrants.
June 2019	Acquired the business operations of Imdecol Ltd.
October 2019	Shareholders approved annual compensation for non-employee/non-consultant directors and a grant of options to purchase 7,500 Ordinary Shares.
December 2019	Eyal Cohen became the sole Chief Executive Officer.
2020	Suffered a limited cybersecurity breach.
December 16, 2020	Compensation Policy for Executive Officers and Directors was approved by a Compensation Majority.
January 4, 2021	Entered into a definitive agreement for the purchase and sale of 800,000 Ordinary Shares and 720,000 warrants.
October 2021	Ms. Osnat Gur joined the Board of Directors.
End of 2021	Intelligent Robotics division began shifting its focus from the US to the Israeli market.
May 2, 2022	Completed the sale of 450,000 Ordinary Shares and 225,000 warrants.
May 2022	Purchased 546 sqm of offices, 495 sqm of warehouses, and nine parking spots in Rishon Le Zion, Israel, for NIS 6.5 million (approximately $1.9 million).
August 2022	BOS-Dimex Ltd. received a loan of $1.28 million (NIS 4,500,000) from Bank Leumi.
October 23, 2022	Extended the expiration date of 300,000 warrants (issued in 2019) to November 16, 2025.
December 15, 2022	Shareholders approved an increase of 3,000,000 Ordinary Shares in authorized share capital (to 11,000,000) and an increase of 300,000 Ordinary Shares in the pool for the Plan (total 1,000,000).
April 2, 2023	Proteus sold its share in a joint activity to the Company for $723,000.
May 28, 2023	Board of Directors approved a 10-year extension to the Share Option Plan (through May 31, 2033).
May 31, 2023	Acquired distribution rights from Microwave Ltd. for $38,000.
October 7, 2023	Hamas launched coordinated attacks on Israel, leading to Israel declaring war.
December 14, 2023	Shareholders approved the Company's Compensation Policy, including a clawback provision.
December 2023	Shareholders did not approve the extension of the Plan for Incentive Stock Options (ISOs).
January 2024	The International Court of Justice (ICJ) issued an interim ruling in a case filed by South Africa against Israel.
August 8, 2024	Issued 37,500 options to directors and officers.
September 2024	Moody's rating agency lowered Israel's credit rating from A2 to Baa1.
October 15, 2024	Articles of Association amended regarding special meeting requisitions and director nominations.
October 2024	S&P Global and Fitch downgraded Israel's credit rating from A+ to A.
November 2024	Israel entered into a ceasefire arrangement with Hezbollah.
December 5, 2024	Issued 21,208 shares to the CEO.
December 2024	Shareholders approved an increase in the triennial option grant to 15,000 Ordinary Shares (from 7,500).
January 21, 2025	Todd M. Felte filed Schedule 13G/A, beneficially owning 6.5% of outstanding shares as of March 15, 2026.
March 2025	Ms. Osnat Gur was appointed Chairman of the Board of Directors, with a retroactive increase in annual compensation. Mr. Avi Dadon joined the Board of Directors.
April 2025	Mandatory minimum wage in Israel increased by approximately 6% to NIS 6,247.67 per month.
May 25, 2025	Issued 25,000 options to directors and officers.
June 2025	Israel launched a preemptive strike targeting military and nuclear infrastructure inside Iran; Iran responded; a ceasefire was reached after 12 days of hostilities.
June 30, 2025	Interim goodwill impairment analysis performed, resulting in a $700,000 impairment loss.
September 3, 2025	Proxy statement filed with the SEC regarding director and CEO compensation.
September 15, 2025	Entered into a sales agreement with A.G.P./Alliance Global Partners for an at-the-market offering of up to $4 million of Ordinary Shares.
October 9, 2025	Israel and Hamas entered into a ceasefire agreement calling for a permanent end to the war.
October 13, 2025	Israel reached a ceasefire agreement with Hamas.
October 2025	Shareholders approved bonuses for the CEO and CFO, payable in Ordinary Shares.
October 30, 2025	Shareholders approved a modified indemnification agreement for directors and officers.
November 7, 2025	S&P Global Ratings revised its outlook on Israel to stable from negative, affirming 'A/A-1' ratings.
November 16, 2025	Expiration date of 300,000 warrants (issued in 2019); all were exercised in 2025.
December 18, 2025	Obtained a short-term bank loan of NIS 2,000,000 (approximately $621,000).
December 31, 2025	Fiscal year ended. Annual goodwill impairment analysis performed, resulting in an additional $500,000 impairment loss.
January 2026	The short-term bank loan obtained on December 18, 2025, was fully repaid.
February 28, 2026	Israel and the United States launched a combined attack against government targets in Iran; Iran responded; Hezbollah opened fire on Israel, expanding the fighting front.
March 2026	Acquired Qpaz Technologies Ltd. and Keren Lahav 3 L.P.'s rights and obligations under a joint venture agreement for NIS 2,000,000 (approximately $641,000).
March 15, 2026	Number of outstanding Ordinary Shares was 7,049,810.
March 31, 2026	Filing date of the Annual Report on Form 20-F.
April 4, 2026	Special state of emergency in Israel declared until this date.
April 2026	Mandatory minimum wage in Israel is due to increase to NIS 6,443.85 per month.
2026	Company plans to invest in expanding the RFID division into more stable regulated sectors, including medical and defense.
2027	Revenue contributions from the RFID division's expansion into new sectors are expected to begin.
May 31, 2033	Extended expiration date for the 2003 Israeli Share Option Plan.

Recommendation

buy

The company demonstrated strong financial performance in 2025, with significant revenue and net income growth, and a substantial increase in operating cash flow. The strategic pivot towards the defense sector for its Supply Chain Solutions and Intelligent Robotics divisions is capitalizing on a growing market, providing a robust growth driver. While the RFID division faces challenges and goodwill impairment was recorded, the overall financial health and strategic direction are positive. The company's improved liquidity and profitability, despite geopolitical risks, suggest a favorable outlook for long-term investors.

Keywords

Supply Chain Solutions, RFID, Intelligent Robotics, Defense Industry, Electronic Components, Inventory Management, Automation, Israel, SEC Filing, Annual Report, Nasdaq, Financial Results, Goodwill Impairment, Geopolitical Risk

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.